Litcius/Paper detail

Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 study

Alexandre Bazinet, Guillermo Garcia‐Manero, Nicholas J. Short, Yesid Alvarado, Álex Bataller, Tareq Abuasab, Rabiul Islam, Kathryn Montalbano, Ghayas C. Issa, Abhishek Maiti, Musa Yılmaz, Nitin Jain, Lucia Masárová, Steven M. Kornblau, Elias Jabbour, Guillermo Montalban‐Bravo, Caitlin R. Rausch, Sherry Pierce, Courtney D. DiNardo, Tapan M. Kadia, Naval Daver, Marina Konopleva, Xuelin Huang, Hagop M. Kantarjian, Farhad Ravandi

2024The Lancet Haematology23 citationsDOIOpen Access PDF

Topics & Concepts

DecitabineVenetoclaxMedicineAzacitidineMyeloid leukemiaMyeloidInternal medicineLeukemiaOncologyChronic lymphocytic leukemiaGeneticsDNA methylationGene expressionBiologyGeneAcute Myeloid Leukemia ResearchEpigenetics and DNA MethylationImmune cells in cancer